Trial Profile
Phase IIa trial of SAM 101 in patients with early-stage schizophrenia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Dec 2011
Price :
$35
*
At a glance
- Drugs SAM 101 (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 19 Dec 2011 New trial record